Микробы внутри нас. Как поддерживать баланс микрофлоры кишечника для идеального пищеварения и крепкого иммунитета

McColl, K.E., Gillen, D. Evidence that proton-pump inhibitor therapy induces the symptoms it is used to treat. Gastroenterology 2009; 137(1): 20–22.

Schubert, M.L. Gastric secretion. Curr Opin Gastroenterol 2014; 30(6): 578–582.

Spiegel, B.M., Chey, W.D., Chang, L. Bacterial overgrowth and irritable bowel syndrome: unifying hypothesis or a spurious consequence of proton pump inhibitors? Am J Gastroenterol 2008; 103(12): 2972–2976.

Yago, M.R., et cols. Gastric reacidification with betaine HCl in healthy volunteers with rabeprazole-induced hypochlorhydria. Molecular pharmaceutics 2013; 10(11): 4032–4037.

Nofrarías, M.; Martínez-Puig, D.; Pujols, J.; Majó, N.; Pérez, J.F. Long-term intake of resistant starch improves colonic mucosal integrity and reduces gut apoptosis and blood immune cells. Nutrition. 2007 Nov-Dec; 23(11-12): 861–870.

Morita, T.; Tanabe, H.; Sugiyama, K.; Kasaoka, S.; Kiriyama, S. Dietary resistant starch alters the characteristics of colonic mucosa and exerts a protective effect on trinitrobenzene sulfonic acid-induced colitis in rats. Biosci Biotechnol Biochem. 2004 Oct; 68(10): 2155–2164.

Bodinham, C.L.; Frost, G.S.; Robertson, M.D. Acute ingestion of resistant starch reduces food intake in healthy adults. Br J Nutr. 2010 Mar; 103(6): 917–922.

Villarroel, P.; Gómez, C.; Vera, C.; Torres, J. Almidón resistente: Características tecnológicas e intereses fisiológicos. Rev chil nutr 2018; 45(3): 271–278.

Strachan, D.P. Hay fever, hygiene, and household size. BMJ 1989; 299(6710): 1259–1260.

Okada, H.; Kuhun, C.; Feillet, H.; Bach, J.F. The «hygiene hypothesis» for autoimmune and allergic diseases: an update. Clin Exp Immunol 2010; 160(1): 1–9.

Linch, S.V., et cols. Effects of early-life exposure to allergens and bacteria on recurrent wheeze and atopy in urban children. JACI 2014; 134(3): 593–601.

Kozyrskyj, A.L.; Ernst, P.; Becker, A.B. Increased risk of childhood asthma from antibiotic use in early life. Epub 2007; 131(6): 1753–1759.

What is the Healthy Gut Microbiota Composition? A Changing Ecosystem across Age, Environment, Diet, and Diseases. Microorganisms 2019; 7(1): 14.

Castillo-Álvarez, F.; Marzo-Sola, M.E. Papel de la microbiota intestinal en el desarrollo de la esclerosis múltiple. Neurología 2017; 32(3): 175–184.

Icaza-Chávez, M.E. Gut microbiota in health and disease. Rev Gastroenterol Mex 2013; 78(4): 240–248.

Houghton, D.; Stewart, CJ.; Day, CP.; Trenell, M. Gut microbiota and lifestyle interventions in NAFLD. Int J Mol Sci. 2016; 17: 447.

Conlon, M.A.; Bird, A.R. The impact of diet and lifestyle on gut microbiota and human health. Nutrients. 2015; 7: 17–44.

Marsland, B.J. Influences of the Microbiome on the Early Origins of Allergic Asthma. Ann Am Thorac Soc. 2013; 10: S165–9.

Madan, J.C.; Koestler, D.C.; Stanton, B.A.; Davidson, L.; Moulton, L.A.; Housman, M.L.; et al. Serial analysis of the gut and respiratory microbiome in cystic fibrosis in infancy: interaction between intestinal and respiratory tracts and impact of nutritional exposures. MBio. 2012;3: e00251–12.

Nguyen, H.B.; Rivers, E.P.; Abrahamian, F.M. y cols. Severe sepsis and septic shock: review of the literature and emergency department management guidelines. Ann Emerg Med 2006; 48: 28–54.

Translocación bacteriana. Nutr. Hosp. [Internet]. 2007 Mayo [citado 2019 Ago 02]; 22 (Suppl 2): 50-55. Disponible en: http: //scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0212– 16112007000500007&lng=es

Logan, A.C.; Jacka, F.N.; Prescott, S.L. Immune-microbiota interactions: Dysbiosis as a global health issue. Curr Allergy Asthma Rep. 2016; 16: 13.

Caballero, S.; Pamer, E.G. Microbiota-Mediated Inflammation and Antimicrobial Defense in the Intestine. Annu. Rev. Immunol. 2015; 33: 9.1–9.30.

García-Mazcorro, J.F., et cols. Caracterización, influencia y manipulación de la microbiota gastrointestinal en salud y enfermedad. Gastroenterol Hepatol 2015; 38(7): 445–466.

Guarner, F. Microbiota intestinal y enfermedades inflamatorias del intestino. Gastroenterol Hepatol 2011; 34(3): 147–154.

Herrero de Lucas, E., et cols. Interacciones entre el huésped y la microbiota. Medicine 2018; 12(52): 3059–3065.

Sebastián Domingo, J.J.; Sánchez Sánchez, C. De la flora intestinal al microbioma. Rev Esp Enferm Dig 2018; 110(1): 51–56.

Rinninella, E., et cols. What is the Healthy Gut Microbiota Composition? A Changing Ecosystem across Age, Environment, Diet, and Diseases. Microorganisms 2019; 7(1): 14.

Serrano, C.A., et cols. Desarrollo del microbioma intestinal en niños. Impacto en la salud y en la enfermedad. Rev Chil Pediatr 2016; 87(3): 151–153.

Stewart, C.J., et cols. Temporal development of the gut microbiome in early childhood from the TEDDY study. Nature 2018; 562 (7728): 583–588. Disponible en: http://scielo.isciii.es/ pdf/diges/v107n11/es_revision.pdf

Guarner, F., et cols. Probiotics and prebiotics. WGO Global Guidelines 2017.